Restech

Houston, United States Founded: 2003 • Age: 23 yrs
Provider of patient health diagnosis and treatment management devices for providers

About Restech

Restech is a Healthcare company based in Houston (United States) founded in 2003 by Jeff Schipper. Provider of patient health diagnosis and treatment management devices for providers. Restech has raised $304.98 thousand across 1 funding round. Restech has completed 1 acquisition, including Mederi Therapeutics. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include QuidelOrtho, ProciseDx and WuXi Diagnostics; 2 of its 3 listed competitors have raised funding.

Company details

Medical devices for patient health diagnosis and treatment management are supplied by Restech to healthcare providers. Founded in 2003 and based in Houston, United States, the company focuses on gastrointestinal sector operations. Devices are designed to aid physicians in identifying refluxes and fecal abnormalities, with capabilities for displaying warnings and analyzing therapeutic pathways included.

  • Headquarters Houston, United States
  • Founders Jeff Schipper
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website restech.com
  • Social LinkedIn X Facebook
Key Metrics
  • Total Equity Funding
    $304.98K (USD)

    in 1 rounds

  • Latest Funding Round
    $304.98K (USD), Seed

    Nov 2023

  • Investments & Acquisitions

Funding Insights of Restech

Restech has successfully raised a total of $304.98K through 1 strategic funding round. The most recent funding activity was a Seed round of $304.98 thousand completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $304,975
  • Total Rounds 1
  • Last Round Seed β€” $304,975
  • First Round $304,975

    (Nov 2023)

All 1 funding rounds of Restech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2023$304,975Seed––
–

People of Restech

7 people are tracked at Restech (3 in leadership, 4 in team).

NameRoleGroup
Jeff Schipper
Co-FounderLeadership
Leo Roucher
President & CEOLeadership
Brandon Wang
Director Of FinanceLeadership
Lauren Fisk
Regional Manager, Western DivisionTeam
Dan Huff
Sales RepresentativeTeam
Remigio Jalomo (Ray)
Warehouse ManagerTeam
Jehad Nsir
SalesTeam
Premium access

Complete people profiles for Restech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Restech

Restech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Mederi Therapeutics.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Minimally invasive RF devices for gastrointestinal diseases are developed.
mederi-inc.comGreenwich, United States2008Apr 2018β€’β€’β€’β€’
Premium access

Complete acquisition details for Restech

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Restech

3 dated milestones of Restech across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded Restech is founded.
  2. Acquisition Acquires Mederi Therapeutics.
  3. Funding First funding round of $305K.

Competitors of Restech

Restech has 3 listed competitors in our database, 2 of them funded. They include QuidelOrtho, ProciseDx and WuXi Diagnostics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
quidelortho.com1937San Diego, United States278
Provider of healthcare information services
procisedx.com2018San Diego, United States$8.96M
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
wuxidiagnostics.com2018Rochester, United States$200M
Diagnostic solutions for disease identification are offered to healthcare providers.
Premium access

Detailed competitors of Restech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Restech

Websites that share an audience with Restech (restech.com).

Similar websites

Websites whose visitors overlap most with Restech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
vitas.com
100%
213K#191,178View details
alfascientific.com
100%
#8,547,751View details
clinicalfoundations.org
clinicalfoundations.org
100%
–
truvianhealth.com
99%
4.2K#4,492,336View details
sekisuidiagnostics.com
98%
#2,255,959View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Restech

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Restech (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Restech

Restech was founded in 2003 and raised its 1st funding round 20 years after it was founded.

Restech is headquartered in Houston, United States. It is registered at Houston, Texas, United States.

Restech is a funded company, having raised a total of $304.98K across 1 funding round to date. The company's 1st funding round was a Seed of $304.98K, raised on Nov 2023.

Medical devices for patient health diagnosis and treatment management are supplied by Restech to healthcare providers. Founded in 2003 and based in Houston, United States, the company focuses on gastrointestinal sector operations. Devices are designed to aid physicians in identifying refluxes and fecal abnormalities, with capabilities for displaying warnings and analyzing therapeutic pathways included.

Restech's top competitors include QuidelOrtho, ProciseDx and WuXi Diagnostics.

Restech has made 1 acquisition, including Mederi Therapeutics.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available